Exploiting WT1 Genomic Alterations for Target Identification and MRD Monitoring in Pediatric AML |
Fred Hutchinson Cancer Research Center / Phoenix Ho |
Young Investigator Grants |
2012 |
Washington |
Hematopoietic Stem And Progenitor Cells Sustain Inflammation And Promote Relapse In The AML Niche |
Children’s Hospital of Philadelphia / Ding-Wen (Roger) Chen, PhD |
Young Investigator Grants |
2021 |
Pennsylvania |
Kidney Disease after CD19-Targeted Chimeric Antigen Receptor T Cell Therapy for Pediatric Acute Lymphoblastic Leukemia |
Children’s Hospital of Philadelphia / Regina Myers, MD |
Young Investigator Grants |
2019 |
Pennsylvania |
The TC3 Line, a Zebrafish Model of T-Cell Malignancy
|
Huntsman Cancer Institute / Nathan Meeker, MD |
Young Investigator Grants |
2008 |
Utah |
Immunotherapy Of Neuroblastoma With Natural Killer T Cells Engineered To Target O-acetyl-GD2 |
Baylor College of Medicine / Andras Heczey, MD |
Young Investigator Grants |
2014 |
Texas |
Therapeutic Targeting of Childhood Leukemia by Pharmacological Inhibition of Proteolytic Cleavage of MLL1 |
Northwestern University (Illinois) / Zibo Zhao, PhD |
Young Investigator Grants |
2018 |
Illinois |
Targeting the Mechanism of Differentiation Arrest in a Novel Model of Acute Leukemia |
Massachusetts General Hospital / David Sykes |
Young Investigator Grants |
2011 |
Massachusetts |
The Effect of Locus of Care Upon Adolescent and Young Adults Cancer Outcomes: An IMPACT Cohort Study |
Hospital for Sick Children / Sumit Gupta, MD, PhD |
Young Investigator Grants |
2015 |
Ontario |
Identifying Epistatic Suppressors of Oncohistone in Pediatric High-Grade Gliomas |
BC Cancer (Provincial Health Services Authority) / Carol Chen, PhD |
Young Investigator Grants |
2020 |
British Columbia |
Function and Dependency of NFkB Activity in ZFTA-RELA Fusion Ependymoma |
Baylor College of Medicine / Austin Stuckert, MD |
Young Investigator Grants |
2021 |
Texas |